The role of C5a in acute lung injury induced by highly pathogenic viral infections

Emerging Microbes and Infections

Volumn 4, Issue , 2015, Pages

  Wang, Renxi ^a   Xiao, He ^a   Guo, Renfeng ^b,c   Li, Yan ^a   Shen, Beifen ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

acute lung injury; C5a; pro inflammatory cytokines

Indexed keywords

CD28 ANTIGEN; CD40 LIGAND; CELL ADHESION MOLECULE; COMPLEMENT COMPONENT C5A; HISTONE; INTERLEUKIN 12; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ADAPTIVE IMMUNITY; ARTICLE; BIOLOGICAL ACTIVITY; CELL ACTIVATION; CELL MIGRATION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CORONAVIRIDAE; CYTOKINE STORM; EXTRACELLULAR TRAP; HUMAN; INFLAMMATORY CELL; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N9; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; SARS CORONAVIRUS; SIGNAL TRANSDUCTION; VIRUS INFECTION; VIRUS VIRULENCE; ANIMAL; COMPLICATION; DISEASE MODEL; IMMUNOLOGY; METABOLISM; PATHOGENICITY; VIROLOGY; VIRUS;

INFLUENZA A VIRUS; SARS CORONAVIRUS;

ACUTE LUNG INJURY; ANIMALS; COMPLEMENT C5A; DISEASE MODELS, ANIMAL; HUMANS; REACTIVE OXYGEN SPECIES; VIRUS DISEASES; VIRUSES;

EID: 84928879766     PISSN: None     EISSN: 22221751     Source Type: Journal    
DOI: 10.1038/emi.2015.28     Document Type: Article

References (104)

1. Ackerman SK, Friend PS, Hoidal JR, Douglas SD. Production of C2 by human alveolar macrophages. Immunology 1978; 35: 369-372.
2. Cole FS, Matthews WJ, Rossing TH, Gash DJ, Lichtenberg NA, Pennington JE. Complement biosynthesis by human bronchoalveolar macrophages. Clin Immunol Immunopathol 1983; 27: 153-159.
3. Strunk RC, Eidlen DM, Mason RJ. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest 1988; 81: 1419-1426.
4. Garcia CC, Weston-Davies W, Russo RC et al. Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury. PLoS One 2013; 8: e64443.
5. Sun S, Zhao G, Liu C et al. Inhibition of Complement Activation Alleviates Acute Lung Injury Induced by Highly Pathogenic Avian Influenza H5N1 Virus Infection. Am J Respir Cell Mol Biol 2013; 49: 221-230.
6. Sun S, Zhao G, Liu C et al. Treatment With Anti-C5a Antibody Improves the Outcome of H7N9 Virus Infection in African Green Monkeys. Clin Infect Dis 2014; 60: 586-595.
7. Huang KJ, Su IJ, Theron M. et al. An interferon-gamma-related cytokine storm in SARS patients. J Med Virol 2005; 75: 185-194.
8. Zhou J, Chu H, Li C et al. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis 2014; 209: 1331-1442.
9. Pandya PH, Wilkes DS. Complement system in lung disease. Am J Respir Cell Mol Biol 2014; 51: 467-473.
10. Guo RF, Ward PA. Role of C5a in inflammatory responses. Annu Rev Immunol 2005; 23: 821-852.
11. Chan JF, To KK, Tse H, Jin DY, Yuen KY. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol 2013; 21: 544-555.
12. Chan JF, To KK, Chen H, Yuen KY. Cross-species transmission and emergence of novel viruses from birds. Curr Opin Virol 2015; 10: 63-69.
13. Al-Tawfiq JA. Middle East Respiratory Syndrome-coronavirus infection: an overview. J Infect Public Health 2013; 6: 319-322.
14. Maltezou HC, Tsiodras S. Middle East respiratory syndrome coronavirus: Implications for health care facilities. Am J Infect Control 2014; 42: 1261-1265.
15. Meliopoulos VA, Karlsson EA, Kercher L et al. Human H7N9 and H5N1 influenza viruses differ in induction of cytokines and tissue tropism. J Virol 2014; 88: 12982-12991.
16. Ng WF, To KF, Lam WW, Ng TK, Lee KC. The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1: a review. Hum Pathol 2006; 37: 381-390.
17. To KK, Chan JF, Chen H, Li L, Yuen KY. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect Dis 2013; 13: 809-821.
18. Yu L, Wang Z, Chen Y et al. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A (H7N9) virus. Clin Infect Dis 2013; 57: 1449-1457.
19. Tran TH, Nguyen TL, Nguyen TD et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350: 1179-1188.
20. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005; 11: 201-209.
21. Szretter KJ, Gangappa S, Lu X et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses inmice. J Virol 2007; 81: 2736-2744.
22. Perlman S. The Middle East respiratory syndrome-how worried should we be? MBio 2013; 4. pii: e00531-13.
23. Hendrickson CM, Matthay MA. Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic. Semin Respir Crit Care Med 2013; 34: 475-486.
24. Stoermer KA, Morrison TE. Complement and viral pathogenesis. Virology 2011; 411: 362-373.
25. Huber-Lang M, Sarma VJ, Lu KT et al. Role of C5a in multiorgan failure during sepsis. J Immunol 2001; 166: 1193-1199.
26. Nascimento EJ, Silva AM, Cordeiro MT et al. Alternative complement pathway deregulation is correlated with dengue severity. PLoS One 2009; 4: e6782.
27. Kanmura S, Uto H, Sato Y et al. The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma. J Gastroenterol 2010; 45: 459-467.
28. Bouvier NM, Palese P. The biology of influenza viruses. Vaccine 2008; 26 Suppl 4:D49-53.
29. Bjornson AB, Mellencamp MA, Schiff GM. Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis 1991; 143: 1062-1066.
30. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006; 440: 435-436.
31. van Riel D, Munster VJ, de Wit E et al. H5N1 Virus Attachment to Lower Respiratory Tract. Science 2006; 312: 399.
32. Berdal JE, Mollnes TE, Weehre T et al. Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza. J Infect 2011; 63: 308-316.
33. MarcMM, Korosec P, KosnikMet al. Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma.AmJ Respir Cell Mol Biol 2004; 31: 216-219.
34. Ohta R, Torii Y, Imai M, Kimura H, Okada N, Ito Y. Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza. Microbiol Immunol 2011; 55: 191-198.
35. O'Brien KB, Morrison TE, Dundore DY, Heise MT, Schultz-Cherry S. A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection. PLoS One 2011; 6: e17377.
36. Trujillo G, Zhang J, Habiel DM et al. Cofactor regulation of C5a chemotactic activity in physiological fluids: Requirement for the vitamin D binding protein, thrombospondin- 1 and its receptors. Mol Immunol 2011; 49: 495-503.
37. Wang CH, Liu CY, Wan YL et al. Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS. Respir Res 2005; 6: 42.
38. Stevens JH, Raffin TA. Adult respiratory distress syndrome-I. Aetiology and mechanisms. Postgrad Med J 1984; 60: 505-513.
39. Tate RM, Repine JE. Neutrophils and the adult respiratory distress syndrome: state of the art. Am Rev Respir Dis 1983; 128: 802-806.
40. Craddock PR, Hammerschmidt A, White JG, Dalmasso AP, Jacob HS. Complement (C5a)-induced granulocyte aggregation in vitro: a possible mechanism of complement-induced leukostasis and leukopenia. J Clin Invest 1977; 60: 260-264.
41. Sacks T, Moldow CF, Craddock PR, Bowers TK, Jacobs HS. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J Clin Invest 1978; 61: 1161-1167.
42. Williams TJ, Jose PJ. Neutrophils in chronic obstructive pulmonary disease. Novartis Found Symp 2001; 234: 136-141.
43. Wang L, Han G, Wang RX et al. Regulation of IL-8 production by complement activated product, C5a, in vitro and in vivo during sepsis. Clin Immunol 2010; 137: 157-165.
44. Cheng OZ, Palaniyar N. NET balancing: a problem in inflammatory lung diseases. Front Immunol 2013; 4: 1-13.
45. Narasaraju T, Yang E, Samy RP et al. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 2011; 179: 199-210.
46. Ng HH, Narasaraju T, Phoon MC, Sim MK, Seet JE, Chow VT. Doxycycline treatment attenuates acute lung injury in mice infected with virulent influenza H3N2 virus: involvement of matrix metalloproteinases. Exp Mol Pathol 2012; 92: 287-295.
47. Yousefi S, Mihalache C, Kozlowski E, Schmid I, Simon HU. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ 2009; 16: 1438-1444.
48. Saffarzadeh M, Juenemann C, QueisserMet al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PloS One 2012; 7: e32366.
49. Aarbiou J, Tjabringa GS, VerhooselRM et al. Mechanisms of cell death induced by the neutrophil antimicrobial peptides alphadefensins and LL-37. Inflamm Res 2006; 55: 119-127.
50. Domej W, Oettl K, Renner W. Oxidative stress and free radicals in COPD-implications and relevance for treatment. Int J Chron Obstruct Pulmon Dis 2014; 9: 1207-1224.
51. Akaike T, Ando M, Oda T et al. Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest 1990; 85: 739-745.
52. Mollnes TE, Brekke OL, Fung M et al. Essential role of the C5a receptor in E. coliinduced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 2002; 100: 1869-1877.
53. Sprong T, Brandtzaeg P, Fung M et al. Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis. Blood 2003; 102: 3702-3710.
54. Kunsch C, Lang RK, Rosen CA, Shannon MF. Synergistic transcriptional activation of the IL-8 gene by NF-kB p65 (RelA) and NF-IL-6. J Immunol 1994; 153: 153-164.
55. Jacoby DB, Choi AMK. Influenza virus infection induces differential expression of antioxidant genes in human airway epithelial cells. Free Radic Biol Med 1994; 16: 821-824.
56. Husain M, Cheung CY. Histone deacetylase 6 inhibits influenza A virus release by downregulating the trafficking of viral components to the plasma membrane via its substrate, acetylated microtubules. J Virol 2014; 88: 11229-1139.
57. PrakashS, Agrawal S, Cao JN, Gupta S, Agrawal A. Impaired secretion of interferons by dendritic cells from aged subjects to influenza: role of histone modifications. Age (Dordr) 2013; 35: 1785-1797.
58. Grailer JJ, Canning BA, Kalbitz M et al. Critical role for the NLRP3 inflammasome during acute lung injury. J Immunol 2014; 192: 5974-5983.
59. Brinkmann V, Zychlinsky A. Neutrophil extracellular traps: is immunity the second function of chromatin? J Cell Biol 2012; 198: 773-783.
60. Bosmann M, Grailer JJ, Ruemmler R et al. Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury. FASEB J 2013; 27: 5010-5021.
61. Guo RF, Ward PA. Mediators and regulation of neutrophil accumulation in inflammatory responses inlung: insights from the IgG immune complex model. Free Radic Biol Med 2002; 33: 303-310.
62. Ward PA. Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann N Y Acad Sci 1996; 796: 104-112.
63. Jagels MA, Daffern PJ, Hugli TE. C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. Immunopharmacology 2000; 46: 209-222.
64. Molad Y, Haines KA, Anderson DC, Buyon JP, Cronstein BN. Immuno-complexes stimulate different signalling events to chemoattractants in the neutrophil and regulate L-selectin and b2-integrin expression differently. Biochem J 1994; 299(Pt 3): 881-887.
65. Foreman KE, Glovsky MM, Warner RL, Horvath SJ, Ward PA. Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells. Inflammation 1996; 20: 1-9.
66. McHale JF, Harari OA, MarshallD, Haskard DO. Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF-a. J Immunol 1999; 162: 1648-1655.
67. Morelli A, Larregina A, Chuluyan I, Kolkowski E, Fainboim L. Expression and modulation of C5a receptor (CD88) on skin dendritic cells: chemotactic effect of C5a on skin migratory dendritic cells. Immunology 1996; 89: 126-134.
68. Sozzani S, Sallusto F, Luini W et al. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J Immunol 1995; 155: 3292-3295.
69. Nataf S, Davoust N, Ames RS, Barnum SR. Human T cells express the C5a receptor and are chemoattracted to C5a. J Immunol 1999; 162: 4018-4023.
70. Tsuji RF, Kawikova I, Ramabhadran R et al. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol 2000; 165: 1588-1598.
71. Ottonello L, Corcione A, Tortolina G et al. rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues. J Immunol 1999; 162: 6510-6517.
72. Mrowietz U, Koch WA, Zhu K et al. Psoriasis scales contain C5a as the predominant chemotaxin for monocyte-derived dendritic cells. Exp Dermatol 2001; 10: 238-245.
73. Yang D, Chen Q, Stoll S, Chen X, Howard OM, Oppenheim JJ. Differential regulation of responsiveness to fMLP and C5a upon dendritic cell maturation: correlation with receptor expression. J Immunol 2000; 165: 2694-2702.
74. Kim AH, Dimitriou ID, Holland MC et al. Complement C5a receptor is essential for the optimal generation of antiviral CD81T cell responses. J Immunol 2004; 173: 2524-2529.
75. Strainic MG, Liu J, Huang D et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD41 T cells. Immunity 2008; 28: 425-435.
76. Kwan WH, van der Touw W, Paz-Artal E, Li MO, Heeger PS. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J Exp Med 2013; 210: 257-268.
77. Smits SL, van den Brand JM, de Lang A et al. Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species. J Virol 2011; 85: 4234-4245.
78. Hopken U, Mohr M, Struber A et al. Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies. Eur J Immunol 1996; 26: 1103-1109.
79. Strieter RM, Kasahara K, Allen RM et al. Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol 1992; 141: 397-407.
80. Chan MC, Cheung CY, Chui WH et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005; 6: 135.
81. Burggraaf S, Karpala AJ, Bingham J et al. H5N1 infection causes rapid mortality and high cytokine levels in chickens compared to ducks. Virus Res 2014; 185: 23-31.
82. Perrone LA, Szretter KJ, Katz JM, Mizgerd JP, Tumpey TM. Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. J Infect Dis 2010; 202: 1161-1170.
83. Huang R, Zhang L, Gu Q et al. Profiles of acute cytokine and antibody responses in patients infected with avian influenza A H7N9. PLoS One 2014; 9: e101788.
84. Li Y, Chen M, Cao H, Zhu Y, Zheng J, Zhou H. Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response. Microbes Infect 2013; 15: 88-95.
85. He L, Ding Y, Zhang Q et al. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE21 cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol 2006; 210: 288-297.
86. Webster RG, Walker EJ. The world is teetering on the edge of a pandemic that could kill a large fraction of the human population. American Scientist 2003; 91: 122.
87. Shi X, Zhou W, Huang H et al. Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice. Crit Care 2013; 17: R301.
88. Hou XQ, Gao YW, Yang ST, Wang CY, Ma ZY, Xia XZ. Role of macrophage migration inhibitory factor in influenza H5N1 virus pneumonia. Acta Virol 2009; 53: 225-231.
89. Liu Q, Xiong HR, Lu L et al. Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection. Acta Pharmacol Sin 2013; 34: 1075-1083.
90. Diao H, Cui G, Wei Y et al. Severe H7N9 infection is associated with decreased antigen-presenting capacity of CD141 cells. PLoS One 2014; 9: e92823.
91. Chen Y, Li X, Tian L et al. Dynamic behavior of lymphocyte subgroups correlates with clinical outcomes in human H7N9 infection. J Infect 2014; 69: 358-365.
92. Ward PA. New Strategies for Treatment of Humans With Acute Lung Injury/Acute Respiratory Distress Syndrome. Clin Infect Dis 2015; 60: 596-597.
93. Yoshikawa T, Hill T, Li K, Peters CJ, Tseng CT. Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells. J Virol 2009; 83: 3039-3048.
94. Law HK, Cheung CY, Ng HY et al. Chemokine up-regulation in SARScoronavirus- infected, monocyte-derived human dendritic cells. Blood 2005; 106: 2366-2374.
95. Hao D, He LX, Qu JM et al. A study of pulmonary inflammatory reaction induced by Nprotein of SARS-CoV in rat models and effects of glucocorticoids on it. Zhonghua Nei Ke Za Zhi 2005; 44: 890-893.
96. Yu SY, Hu YW, Liu XY, Xiong W, Zhou ZT, Yuan ZH. Gene expression profiles in peripheral blood mononuclear cells of SARS patients. World J Gastroenterol 2005; 11: 5037-5043.
97. Sun L, Guo RF, Gao H, Sarma JV, Zetoune FS, Ward PA. Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR inlung epithelial cells. FASEB J 2009; 23: 3808-3818.
98. Proctor LM, Strachan AJ, Woodruff TM et al. Complement inhibitors selectively attenuate injury following administration of cobra venom factor to rats. Int Immunopharmacol 2006; 6: 1224-1232.
99. Bosmann M, Ward PA. Protein-based therapies for acute lung injury: targeting neutrophil extracellular traps. Expert Opin Ther Targets 2014; 18: 703-714.
100. Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004; 202: 145-156.
101. Osterholm MT. Preparing for the next pandemic. N Engl J Med 2005; 352: 1839-1842.
102. Haque A, Hober D, Kasper LH. Confronting Potential Influenza A (H5N1) Pandemic with Better Vaccines. Emerg Infect Dis 2007; 13: 1512-1518.
103. Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008; 118: 3546-3556.
104. Ansari AA. Clinical features and pathobiology of Ebolavirus infection. J Autoimmun 2014; 55: 1-9.